Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma-Reference-Cited by-同舟云学术

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Published:2014-01 Issue:1 Volume:50 Page:121-127
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Del Vecchio Michele,Di Guardo Lorenza,Ascierto Paolo A.,Grimaldi Antonio M.,Sileni Vanna Chiarion,Pigozzo Jacopo,Ferraresi Virginia,Nuzzo Carmen,Rinaldi Gaetana,Testori Alessandro,Ferrucci Pier F.,Marchetti Paolo,De Galitiis Federica,Queirolo Paola,Tornari Elena,Marconcini Riccardo,Calabrò Luana,Maio Michele

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Incidence of noncutaneous melanomas in the US;McLaughlin;Cancer,2005

2. Mucosal melanomas: a case-based review of the literature;Seetharamu;Oncologist,2010

3. Mucosal melanoma: pathogenesis, clinical behavior, and management;Postow;Curr Oncol Rep,2012

4. The National Cancer Data Base report on cutaneous and noncutaneous melanoma;Chang;Cancer,1998

5. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma;Balch;J Clin Oncol,2001

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes;Frontiers in Immunology;2024-07-30

2. Survival and Treatment Modalities in Primary Vaginal Melanoma—Case Report and a Narrative Review;Journal of Clinical Medicine;2024-06-27

3. Immunological Profiles in Mucosal Melanoma with Distinct Prognosis;2024

4. Mucosal Melanoma;Melanoma;2024

5. Anorektales Melanom;coloproctology;2023-12-29